IGC Pharma, Inc. (IGC): Total Liabilities
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$2.42M
As of 2025-03-31
-6.3%
3-year compound annual growth
-0.2%
5-year compound annual growth
-8.0%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $2.42M | -6.4% | 2025-06-27, Balance as of period end |
| 2024-03-31 | $2.58M | +13.9% | 2025-06-27, Balance as of period end |
| 2023-03-31 | $2.27M | -22.9% | 2024-06-24, Balance as of period end |
| 2022-03-31 | $2.94M | -4.0% | 2023-07-07, Balance as of period end |
| 2021-03-31 | $3.06M | +25.2% | 2022-06-23, Balance as of period end |
| 2020-03-31 | $2.45M | +174.0% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $893.0K | -68.0% | 2020-07-13, Balance as of period end |
| 2018-03-31 | $2.79M | -29.1% | 2019-06-14, Balance as of period end |
| 2017-03-31 | $3.93M | -19.9% | 2018-06-21, Balance as of period end |
| 2016-03-31 | $4.91M | -12.0% | 2017-07-14, Balance as of period end |
| 2015-03-31 | $5.58M | +55.5% | 2016-07-14, Balance as of period end |
| 2014-03-31 | $3.59M | -16.1% | 2015-07-14, Balance as of period end |
| 2013-03-31 | $4.28M | -54.7% | 2014-07-15, Balance as of period end |
| 2012-03-31 | $9.44M | +21.3% | 2014-07-15, Balance as of period end |
| 2011-03-31 | $7.79M | n/a | 2012-07-16, Balance as of period end |